前列腺穿刺活检诊断筛状Gleason 4级与导管内癌的准确性:配对根治标本研究
本研究评估前列腺穿刺活检检测筛状形态和/或导管内癌(cribriform morphology and/or intraductal carcinoma)与根治标本的一致性,纳入455例根治性前列腺切除患者。活检灵敏度56.5%、特异度87.2%;主动监测候选者灵敏度仅34.1%、特异度88.1%,MRI靶向活检未提高灵敏度(53.5%)。活检阳性与不良病理相关,但多变量回归未显示独立关联,可能因活检灵敏度低。
要点
- 活检检测筛状形态和/或导管内癌灵敏度低(56.5%),主动监测候选者更低(34.1%)。
- 活检特异度高(87.2%),阳性时可用于治疗决策。
- MRI靶向活检未改善灵敏度(53.5%)。
核心结论
- 活检对筛状形态和/或导管内癌检测不敏感,MRI融合未改善,但特异度高,阳性结果可纳入治疗规划。
主要发现
- 455例中216例(47.5%)活检检出筛状形态和/或导管内癌。
- 活检检测筛状形态和/或导管内癌的灵敏度56.5%、特异度87.2%。
- 主动监测候选者中灵敏度34.1%、特异度88.1%。
- MRI靶向活检灵敏度53.5%。
- 根治标本筛状形态和/或导管内癌与不良病理相关,但活检阳性在多变量回归中未独立关联不良病理。
关键数值与推荐
- 灵敏度56.5%、特异度87.2%(整体队列)。
- 主动监测候选者灵敏度34.1%、特异度88.1%。
- MRI靶向活检灵敏度53.5%。
临床怎么用
- 活检检出筛状形态和/或导管内癌时,因特异度高,可考虑纳入治疗规划。
- 活检阴性不能排除筛状形态和/或导管内癌,主动监测评估需谨慎。
局限性
- 活检低灵敏度可能影响独立关联分析,单中心回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostatic adenocarcinoma with cribriform morphology and/or intraductal carcinoma has higher recurrence and mortality rates after radiation and surgery. While the prognostic impact of these features is well studied, concordance with cribriform morphology and/or intraductal carcinoma on biopsy and prostatectomy has only recently gained attention. Our primary objective was to evaluate the diagnostic performance of biopsy to detect cribriform morphology and/or intraductal carcinoma in paired biopsy and prostatectomy specimens in a large contemporary cohort. MATERIALS AND METHODS: Patients who underwent prostate biopsy or had biopsies reviewed prior to prostatectomy at a tertiary hospital between November 2017 and November 2018 were included in study. Sensitivity and specificity were calculated to assess concordance with cribriform morphology and/or intraductal carcinoma on biopsy and prostatectomy. The association of biopsy diagnosed with cribriform morphology and/or intraductal carcinoma with adverse pathology was assessed by multivariable regression. RESULTS: Of the 455 men who underwent prostatectomy 216 (47.5%) had biopsy identified with cribriform morphology and/or intraductal carcinoma. For cribriform morphology and/or intraductal carcinoma the sensitivity and specificity of biopsy was 56.5% and 87.2%, respectively. In men eligible for active surveillance sensitivity was 34.1% and specificity was 88.1%. Magnetic resonance imaging targeted biopsies did not improve sensitivity (53.5%). Cribriform morphology and/or intraductal carcinoma identified on prostatectomy correlated with adverse pathological findings. However, compared to cribriform morphology and/or intraductal carcinoma negative biopsies, biopsies identified with cribriform morphology and/or intraductal carcinoma were not independently associated with adverse pathology. This was likely due to biopsy low sensitivity. CONCLUSIONS: In this cohort biopsy was not sensitive for detecting cribriform morphology and/or intraductal carcinoma and this was not improved by magnetic resonance imaging fusion. However, specificity was high, suggesting that when present on biopsy, cribriform morphology and/or intraductal carcinoma may be considered in treatment planning algorithms.
引用
- Ericson KJ, Wu SS, Lundy SD, et al. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance. J Urol. 2019. PMID: 31483693. doi:10.1097/JU.0000000000000526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。